C

Corteva

Agriculture tech firm: seeds and protections

Overview

Corteva is a global agriculture technology company focused on helping farmers increase yields and protect crops. It offers high-tech seeds (including the Pioneer brand) and crop protection products, plus digital farming tools and gene-editing research to enable data-driven decisions. It differentiates itself as a pure-play agriculture company formed from DowDuPont, with a push into biologicals and a plan to split into two independent companies (seeds and crop protection) by late 2026 to unlock specialized value. Its goal is to meet the food needs of a growing population and improve farm profitability and sustainability through innovation.

Work here?Claim your company

About Corteva

Simplify's Rating
Why Corteva is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Food & AgricultureData & AnalyticsEnterprise SoftwareBiotechnology

Company Size

10,001+

Company Stage

IPO

Headquarters

Indianapolis, IN

Founded

2019

Get referred to Corteva

See people who can refer or advise you

Simplify Jobs

Simplify's take

What believers are saying

  • November 11, 2026 results showed North America sales up 7% and EMEA growth.
  • October 2026 Othos launch expands Corteva's fungicide footprint in Poland and Europe.
  • Management still targets 2029 sales of $8.4 billion to $8.7 billion, implying growth momentum.

What critics are saying

  • November 11, 2026 guidance cut showed Brazil weakness, channel inventories, and financing pressure.
  • September 25, 2026 FTC settlement bans loyalty programs for 10 years, crippling pricing leverage.
  • Generic competition and separation complexity threaten margins, especially as post-spin services and royalties unwind.

What makes Corteva unique

  • November 2026 spin-off left Corteva as a pure-play crop-protection company.
  • September 2026 JV with Globachem extends its reach into differentiated European formulations.
  • Its 2026 pipeline includes 12 launches, with five biologicals and strong R&D efficiency.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$2.4B

Above

Industry Average

Funded Over

3 Rounds

Post IPO Debt funding comparison data is currently unavailable. We're working to provide this information soon!
Post IPO Debt Funding Comparison Coming Soon

Benefits

  • Health Insurance
  • Paid Vacation
  • Parental Leave
  • 401(k) Retirement Plan
  • Professional Development Budget

Stock Price

Company News

Securities.io
Nov 11th, 2026
Corteva Q3 net sales fall 9% as Brazil drives outlook revision.

Corteva Q3 net sales fall 9% as Brazil drives outlook revision. Published November 11, 2026 Ayodele Hassan AgTech, FoodTech & Bioeconomy, AI Research Agent Corteva reported third-quarter net sales of US$1.591 billion in its third-quarter results release on November 11, 2026, down 9% from a year earlier, as a steep contraction in Latin America outweighed growth in other regions. The crop-protection company swung to a $54 million pro forma GAAP loss from continuing operations after tax and revised its full-year outlook, primarily reflecting weaker market conditions in Brazil. Brazil offsets new-product growth. Company-wide volume declined 2%, while pricing fell 7%. Latin America was the main pressure point: net sales dropped 28% to $570 million and volume fell 24%. Corteva linked the region's volume decline to elevated channel inventories and delayed purchasing, and the broader pricing pressure to competition involving late-lifecycle molecules in Brazil and U.S. acetochlor. North America provided the clearest contrast: Corteva said net sales there rose 7%, with volume up 19% as new-product growth and early demand more than offset U.S. acetochlor pricing pressure. EMEA net sales also increased, supported by demand for new and differentiated products while pricing remained flat. The quarter's weakness was therefore concentrated rather than uniform across the business. Adjusted pro forma operating EBITDA, a company-defined measure of ongoing operating performance, still fell 17% to $222 million. That decline connects the regional disparity to the consolidated result: new-product demand and volume gains outside Latin America did not fully offset the Brazilian slowdown and concentrated pricing pressure. For the first nine months of 2026, adjusted pro forma operating EBITDA was approximately flat at $943 million, compared with $937 million a year earlier, while net sales slipped 1% to $5.357 billion. The comparison shows that the third-quarter downturn was sharper than the consolidated nine-month trend. Outlook reflects weaker Brazilian conditions. "Acetochlor pricing in the U.S. was consistent with our expectations, but Brazil was materially weaker than anticipated," Chief Executive Luke Kissam said. Corteva expects full-year 2026 adjusted pro forma operating EBITDA of $1.1 billion to $1.125 billion and adjusted pro forma operating EPS, its company-defined per-share earnings measure, of $0.76 to $0.80. It attributed the revision primarily to deterioration in Brazil, where farmer liquidity constraints, elevated financing costs, just-in-time purchasing and increased pricing pressure have produced a significantly softer crop-protection market than previously anticipated. Corteva said demand for its differentiated new products remained strong and that its operating priorities remained innovation, productivity and disciplined execution. The quarter nevertheless shows the limits of those offsets: growth in North America and EMEA did not fully compensate for weaker Brazilian volumes and pricing. Brazil's channel inventories, farmer liquidity and purchasing behavior are therefore central to assessing subsequent results against the revised full-year ranges. Ayodele Hassan is an AI-generated markets research agent at Securities.io, covering AgTech, FoodTech & Bioeconomy and the public companies, market infrastructure and investable technologies shaping that field. Ayodele Hassan monitors precision agriculture, crop genetics, agricultural robotics, alternative proteins, fermentation, biomaterials, biomimetics, production capacity and farm economics. Coverage follows a systems-minded, sustainable, commercialization-focused perspective, prioritizing first-party announcements, company fundamentals, competitive positioning and developments with material relevance for investors. Articles authored by Ayodele Hassan are AI-generated and reviewed by Securities.io's editorial team to ensure factual accuracy, source quality and responsible coverage. Content is provided for educational purposes and does not constitute investment advice.

PR Newswire
Nov 9th, 2026
Wisner Baum takes on chlorpyrifos manufacturers in new Parkinson's disease lawsuit.

Wisner Baum takes on chlorpyrifos manufacturers in new Parkinson's disease lawsuit. Nov 09, 2026, 08:16 ET Wisner Baum has filed a lawsuit on behalf of a Los Angeles County man who alleges years of chlorpyrifos exposure from neighboring commercial nurseries contributed to his early-onset Parkinson's disease. The complaint names three pesticide companies and three commercial nurseries, alleging that the manufacturers failed to investigate and disclose the neurological risks of chlorpyrifos, and that the nurseries failed to protect nearby residents from exposure. LOS ANGELES, Nov. 9, 2026 /PRNewswire/ - Wisner Baum LLP has filed a lawsuit in Los Angeles County Superior Court against The Dow Chemical Company and Corteva, alleging the companies manufactured and sold the pesticide chlorpyrifos while failing to adequately study and disclose its link to Parkinson's disease. The firm represents a Los Angeles County man who was diagnosed with early-onset Parkinson's disease after years of living next to commercial nurseries that allegedly sprayed chlorpyrifos. The complaint names pesticide companies Corteva, Inc., Corteva Agriscience LLC, and The Dow Chemical Company, which it alleges designed, manufactured, marketed, sold or distributed chlorpyrifos products. According to the complaint, Dow developed chlorpyrifos in the 1950s, and Dow and its affiliated businesses became major manufacturers and sellers of the pesticide in the United States. Corteva announced in February 2020 that it would phase out production of its chlorpyrifos products. The complaint also names three commercial nurseries alleged to have applied chlorpyrifos near the plaintiff's residences: Abeja Nursery, Azul & Verde Nursery, and ABC Nursery, Inc. "Chlorpyrifos manufacturers had decades to study what this chemical does to the human nervous system," said Sasha Shariati, a Wisner Baum attorney representing the plaintiff. "This lawsuit seeks to hold them accountable for what they knew and what they chose not to tell the public." Alleged Failure to Warn and Take Precautions According to the complaint, chlorpyrifos is an organophosphate insecticide that can affect the nervous system. The lawsuit alleges the pesticide companies failed to adequately test for long-term neurological effects, disclose relevant health information, or communicate risks through advertising, training, sales, and other channels outside EPA-approved product labels. It further claims chlorpyrifos was defectively designed and the companies failed to adopt feasible safer designs or formulations. The complaint also alleges the nursery defendants failed to take reasonable steps to limit pesticide drift and other off-site exposure, maintain adequate buffers and application controls, or notify nearby residents about applications. The complaint cites scientific and epidemiological research that it says supports a relationship between chlorpyrifos exposure and Parkinson's disease, and alleges that safer pesticide alternatives were available during the period of exposure. "People living near pesticide applications should not have to guess what is being sprayed or whether it could affect their health," said Shariati. "This case will examine what the defendants knew, how they communicated about chlorpyrifos, and whether reasonable precautions could have reduced exposure to nearby residents." Years of Alleged Drift Exposure The complaint alleges that the plaintiff was exposed to chlorpyrifos from approximately 2003 to 2020 while living near commercial nursery operations in Los Angeles County. From 2003 to 2013, his residence was about 20 feet from one nursery, with no barrier between the properties. From 2017 to 2022, his backyard fence directly bordered another nursery. The lawsuit brings claims under California law for negligent failure to warn, negligent design and strict liability design defect against the pesticide companies, general negligence against all defendants, and trespass against the nurseries. It seeks compensatory and punitive damages. Chlorpyrifos Under Global Scrutiny California moved to end nearly all sales and use of chlorpyrifos by 2020. The European Union has withdrawn its approval of the pesticide, and a global elimination listing under the Stockholm Convention is scheduled to take effect in December 2026. Wisner Baum's Pesticide Litigation Experience Wisner Baum has spent years holding chemical manufacturers accountable for the health effects of their products. Firm partner R. Brent Wisner served as co-lead trial counsel in Johnson v. Monsanto, the first Roundup cancer case to go to trial, which resulted in a landmark jury verdict. The firm is evaluating claims from people diagnosed with Parkinson's disease after exposure or possible exposure to chlorpyrifos. About Wisner Baum Wisner Baum is a plaintiffs' law firm representing individuals harmed by corporate misconduct, dangerous products, and environmental exposure. For more information, visit www.wisnerbaum.com. References * Michael Sargent v. Corteva, Inc., et al., Los Angeles County Superior Court, Case No. 26STCV34705 * Hasan, K. M. M., Barnhill, L. M., Paul, K. C., Peng, C., Zeiger, W., Ritz, B., Arellano, M., Ajnassian, M., Zhang, S., Theint, A. T., Elezi, G., Weinberger, H., Whitelegge, J. P., Bai, Q., Li, S., Burton, E. A., & Bronstein, J. M. (2025). The pesticide chlorpyrifos increases the risk of Parkinson's disease. Molecular Neurodegeneration, 21, Article 3. Media Contact Karla Jo Helms JoTo PR Disruptors 727-777-4629 www.jotopr.com SOURCE Wisner Baum

The Edge Media Group
Nov 4th, 2026
3M commits US$7.35 bil to settle 'forever chemicals'-related claims

3M commits US$7.35 bil to settle 'forever chemicals'-related claims. 04 Nov 2026, 09:38 am BENGALURU (Nov 3): Industrial conglomerate 3M said on Tuesday that it would commit nearly US$7.35 billion over nine years to settle PFAS "forever chemicals"-related personal injury claims. PFAS are a group of manufactured chemicals used in products resistant to heat, stains, grease and water. They have been linked to health issues including liver damage, lower birth weight, reduced antibody response to vaccines, and kidney and testicular cancer. 3M, which is facing thousands of lawsuits over PFAS contamination, did not admit liability and said it was prepared to continue to defend itself in litigation. The settlement addresses about 99% of current personal-injury claims inside and outside the Aqueous Film-Forming Foam Multi-District Litigation (AFFF MDL). About 115,000 to 120,000 plaintiffs are eligible to participate, according to the company. The payment structure includes a US$50 million payment in 2026 and no payments in 2027, with about 20% of payments due in the final two years. 3M expects to record a pre-tax charge of US$5.8 billion in the fourth quarter, adding that the charge would not impact its previously issued forecast. "This settlement is a significant milestone for 3M and substantially reduces litigation uncertainty," CEO William Brown said in a statement on Tuesday. The conglomerate said all remaining and future personal-injury claims, both inside and outside the AFFF MDL, would be managed through several settlement mechanisms. In 2023, 3M reached a US$10.3 billion settlement with a host of US public water systems to resolve water pollution claims tied to "forever chemicals". Many other companies, including DuPont and Corteva, Chemours are facing lawsuits related to PFAS. 3M said on Tuesday that it has successfully completed its previously announced plan to discontinue the manufacture of all PFAS globally by the end of 2025. Uploaded by Liza Shireen Koshy

Agri-Pulse
Oct 28th, 2026
Farm hands west: Eco Farms names Jim Leach president, Meristem selects Matthew Deyle as vice president, Elanco Animal Health appoints Jamie Preston.

Farm hands west: Eco Farms names Jim Leach president, Meristem selects Matthew Deyle as vice president, Elanco Animal Health appoints Jamie Preston. Eco Farms named Jim Leach president, effective Nov. 16. Leach currently serves as the director of foodservice and Southwest sales at Oppy. He will succeed Eco Farms founder Steve Taft and work with him during the leadership transition. Taft plans to retire June 1, 2027, after more than 50 years leading the company. He co-founded the business in 1972 and helped pioneer the U.S. organic avocado market. Jim Leach (LinkedIn photo) Meristem Crop Performance named Matthew Deyle vice president of business development, overseeing growth in Nebraska, Kansas and Colorado. Deyle joins the company after serving as a multi-location manager and agronomist for Nutrien Ag Solutions in south-central Nebraska. He previously held positions with Cargill and Aurora Cooperative and brings more than 25 years of agribusiness experience. Elanco Animal Health appointed Jamie Preston executive vice president and chief people officer, effective Nov. 3. Preston joins the company from Eli Lilly, where she held global human resources leadership roles for 23 years. She will succeed Dave Kinard, who plans to retire at the end of 2026. Marie Bucko has been named interim CEO of the Animal Health Institute, where she has served as chief operating officer since August 2026. She previously held animal health policy roles at Merck and USDA, including chief of staff for veterinary services. Bucko also worked at the National Pork Producers Council and FDA. Mae Sheaffer joined Corteva Agriscience as strategic marketing communications leader in October. She previously served as an adviser in poultry marketing at Elanco and held account leadership roles at Inizio Evoke, MicroMass Communications and The Sandbox Agency. The Council for Producers and Distributors of Agrotechnology named Greg Lindner of Croda Agriculture chairman, succeeding Patrick Ewan of Helena Agri-Enterprises. The association will focus on EPA registration efficiency, PRIA 6, pesticide mitigation, adjuvants and biopesticides. Meagan Kaiser has joined the American Food Power Council, the senior advisory body of the Center for American Food Power. She is chief operating officer and soil scientist at Perry Agricultural Laboratory Inc. in Missouri and co-founded PAL Farm Management LLC with her husband. Kaiser is a past chair of the United Soybean Board and previously served as a legislative assistant to Sen. Kit Bond, R-Mo. The Animal Health Institute has appointed Rachel Gantz as vice president of strategic communications and public affairs. She joins AHI from the Electric Power Research Institute, where she led external communications and media engagement. Gantz previously held communications leadership roles at the National Pork Producers Council and Renewable Fuels Association. Kevin Hartley joined National Veterinary Associates as director of advocacy and government relations in October. He previously spent six years at the American Veterinary Medical Association and held several legislative roles in the U.S. House of Representatives. The Mid America CropLife Association named Jenny Pagel-Guile executive director. She brings more than 20 years of nonprofit leadership experience and will oversee operations, member programs, education and communications across the association's 13-state region. Jenny Pagel-Guile (LinkedIn photo) Ahold Delhaize has appointed Thierry Garnier as its next president and CEO, succeeding Frans Muller. Garnier will join the company as executive vice president on Jan. 11 before taking over as president and CEO and joining the management board. Muller will retire on March 3 and work with Garnier and the supervisory board to support the leadership transition. The National FFA Organization elected six students to its 2026-27 officer team. Josie Jennings of Ohio will serve as president, Cameron Addington of Minnesota as secretary, Joshua Nelson of Idaho as western region vice president, Jazmin Palma of North Carolina as southern region vice president, Teagan Erbele of North Dakota as central region vice president and Aiden Manley of Kentucky as eastern region vice president. The team will lead the organization through a year of service and leadership development. USDA appointed four members to its Tribal Advisory Committee. Agriculture Secretary Brooke Rollins appointed Mark Fox of the Mandan, Hidatsa and Arikara Nation, Enjady Godfrey of Mescalero Apache Telecom, and Evan Whitley of the Choctaw Nation to three-year terms. Rep. Angie Craig, D-Minn., ranking member of the House Agriculture Committee, appointed Bradford Hall, president of Blackfeet Community College, to serve the remainder of a term ending in December 2026. The Pet Food Institute has announced its 2027-2028 Board of Directors officers, led by Reed Howlett, CEO of Wellness Pet Company, as chair. Liz Mascolo, segment president of North America Pet at General Mills, will serve as vice chair; Yvonne Hsu, president of Hill's Pet Nutrition, as treasurer; and Nicki Baty, president of Freshpet, as secretary. Scott Salmon, chief commercial officer of Simmons Foods, will serve as immediate past chair. Veronique Lagrange, founding executive director of the California Dairy Innovation Center, will retire at the end of 2026 after more than six years leading the organization. She will remain with the California Milk Advisory Board through the first quarter of 2027 to support the transition. Before joining the center, Lagrange spent more than 20 years with the U.S. Dairy Export Council. Former Farm Progress editor Todd Fitchette died Oct. 23 from complications following an unexpected illness, according to a post shared by his sister, Julie Henrie. Fitchette spent nearly 13 years with Farm Progress, serving as editor of Western Farm Press and covering agriculture across the western United States. He later worked as a freelance content writer focused on western specialty crop production and issues. He earned a bachelor's degree in information and communications studies from California State University, Chico. Hannah Guthoerl Editorial Intern

Farming Online
Oct 7th, 2026
JT Agro and Corteva expand access to Othos fungicide in Poland.

JT Agro and Corteva expand access to Othos fungicide in Poland. 07 Oct 2026 Partnership accelerates access to disease management solutions for Polish cereal growers JT Agro, a specialist crop protection partner, and Corteva, a leading global agricultural science and innovation company, today announced the launch of Othos, a new liquid fungicide formulation debuting in Poland under the Corteva brand, with expansion planned across Europe. This collaboration enables more growers in Europe to access Othos, a high-quality formulation of two consolidated active ingredients tested and validated by Corteva. Othos uses a dual mode of action fungicide technology to control cereal diseases like powdery mildew, rusts, and Fusarium head blight. Building on an existing partnership between the two companies, the partnership reinforces a shared commitment to delivering reliable, high-quality crop protection solutions that support growers with consistent performance and supply continuity. Jaitej Walia, Director at JT Crop, said: "Farmers need more than performance alone - they need confidence in continuity, supply reliability, and long-term product availability. Othos demonstrates how a focused, product-led partnership can meet those expectations by combining JT Agro's formulation and manufacturing expertise with Corteva's strong commercial presence in key markets. "What makes this collaboration particularly effective is its flexibility. It allows us to work together on selected products across regions, adapting to local agronomic needs while maintaining consistent standards of quality and supply." Murilo Fernandes, Fungicides Marketing Leader, EMEA at Corteva, said: "By collaborating with JT Agro on Othos, Farming is expanding choice and value for farmers while strengthening its fungicide offering in Poland. Othos complement existing Corteva solutions, providing an important resistant management tool and helping growers ensure balanced control of diseases. This agreement reflects a broader evolution in how Farming is building its European portfolio, selectively integrating complementary solutions through partnerships alongside its proprietary innovation pipeline. "Our collaboration with JT Agro enables a flexible supply and commercial model - including co-pack and tailored packaging approaches - that supports faster portfolio expansion while maintaining the reliability and standards expected from Corteva." Under the agreement, JT Agro will manufacture and supply Othos as a formulated liquid product from its JT Grosvenor facility in Huddersfield, UK, while Corteva will lead marketing and distribution in Poland through its established commercial network. Othos is already registered in Poland and will be available commercially from 2027. Registrations of Othos in additional European markets remain under regulatory review, with further expansion being assessed across selected territories based on agronomic demand, market fit, and local approval timelines. The collaboration between JT Agro and Corteva continues to expand across selected European markets, with additional registered solutions and ongoing evaluation of further opportunities across the region.

Recently Posted Jobs

Sign up to get curated job recommendations

Corteva is Hiring for 58 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs